![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 38/43 | (2006.01) |
A61K 38/43 | (2013.01) | ||
A61P 29/00 | (2006.01) | ||
A61P 13/12 | (2006.01) |
(11) | Patento numeris | 3762018 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 19721159.2 |
Europos patento paraiškos padavimo data | 2019-03-08 | |
(97) | Europos patento paraiškos paskelbimo data | 2021-01-13 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2024-02-14 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/NL2019/050153 |
Data | 2019-03-08 |
(87) | Numeris | WO 2019/172766 |
Data | 2019-09-12 |
(30) | Numeris | Data | Šalis |
201862640494 P | 2018-03-08 | US |
(72) |
PICKKERS, Roelof Peter , NL
MEHTA, Ravindra Lall , NL
MURRAY, Patrick Thomas , NL
JOANNIDIS, Michael , NL
VAN DEN BERG, Erik Jan , NL
AREND, Jacques Salomon Robert , NL
|
(73) |
AM-Pharma B.V. ,
Stadsplateau 7, 3521 AZ Utrecht,
NL
|
(54) | RECOMBINANT ALKALINE PHOSPHATASE FOR USE IN TREATING SEPSIS-ASSOCIATED ACUTE KIDNEY INJURY |
RECOMBINANT ALKALINE PHOSPHATASE FOR USE IN TREATING SEPSIS-ASSOCIATED ACUTE KIDNEY INJURY |